Full history for every metric is available with a Kvantra account

Stock profile

Lutronic Corporation (085370.KQ)

Country: South KoreaSector: HealthcareIndustry: Medical - DevicesExchange: KOE

Delisted · last close 10 Oct 2023

Current price
36,700.00 KRW-0.14%
Last close 10 Oct 2023
Benchmarks

Key financial summary

Financials in KRW
201720182019202020212022TTM
Total revenueKRW bn8692115116174264273
Operating profitKRW bn5937
Net profitKRW bn-7-7-21-16284529
EPS reportedKRW1,7511,088
Operating cashflow per shareKRW935.9935.9
Capex per shareKRW82.6682.66
FCF per shareKRW853.2853.2
Free cash flowKRW bn222
Net debtKRW bn-86-71
Book value equityKRW bn161159
Book value per shareKRW6,2316,199
Number of sharesm25.7925.62
DPS (TTM paid)KRW322.0322.0

Financial summary

Financials in KRW
201720182019202020212022TTM
Value
P/E TTMx11.28-
P/B LTMx3.065.78
P/S LTMx1.863.36
P/FCF LTMx22.33600.99
EV/EBITDA LTMx6.7118.32
EV/Sales LTMx1.693.10
Earnings Yield LTM%8.87%4.78%
FCF Yield%4.48%0.17%
Quality
ROE%28.11%32.04%
ROIC%28.28%28.28%
Operating margin%22.27%22.27%
Gross margin%64.11%64.11%
FCF/Sales%8.33%8.33%
Growth and momentum
EPS Growth YoY%+62.98%-22.58%
Sales Growth YoY%+52.12%+26.82%
Net Income Growth YoY%+63.35%-26.23%
FCF Growth%-35.13%-95.25%
Operating Profit Growth%+58.10%-28.83%
Dividend and capital structure
Dividend Yield%1.01%0.88%
Dividend Growth%--
Payout Ratio%11.01%29.03%
FCF/Debtx--
Net Debt/EBITDAx-0.67-0.67
EBIT/Net interestx0.000.00
Net debt/market cap%-17.42%-7.76%
Net debt/Equityx-0.53-0.45
Gross debt/equityx0.000.00

Company overview

Lutronic Corporation, headquartered in Goyang, South Korea, is a global innovator in the development and distribution of advanced laser and related technologies for both aesthetic and medical applications. The company's extensive portfolio encompasses a variety of sophisticated solutions, including: HOLLYWOOD SPECTRA, a distinguished laser platform with proprietary capabilities to diminish unwanted pigmentation and enhance skin luminosity. Accufit, designed to deliver direct muscle activation treatments for refined aesthetic outcomes. LUTRONIC GENIUS, which ensures exceptional precision with every energy pulse. CLARITY II, a cutting-edge dual-wavelength laser platform featuring intelligent breakthrough functionalities. LaseMD Ultra, providing tailored patient results with virtually no recovery period. SPECTRA XT, recognized as a state-of-the-art medical device. CLARITY, another dual-wavelength platform offering broad treatment versatility and increased operational speed. LASEMD, an adaptable platform capable of implementing a cosmeceutical delivery system for comprehensive skincare. SPECTRA, known for its effective treatments that require minimal patient downtime. PICOPLUS, specifically engineered for the treatment of melasma. ACTION II, which utilizes specialized multiple stacking fractional technology, allowing clinicians to control ablation depth and coagulation for a nearly painless procedure. Lutronic’s offerings further extend to include: eCO2, a premier fractional ablative CO2 laser. INFINI, a unique technology that delivers fractional radiofrequency energy through insulated microneedles. HEALITE II, which therapeutically harnesses incident light to modulate cellular function. SOLARI, an advanced IPL system. In addition to individual devices, the company provides integrated solutions such as: TotalSkin Solution, a comprehensive approach designed to address all layers of the skin and satisfy diverse patient expectations. KeraFactor Peptide Complex, a specialized treatment targeting hair and scalp health. The Hollywood Laser Peel, a swift and comfortable procedure facilitated by the Lutronic Spectra laser platform. Founded in 1997, the company was initially known as Max Engineering Ltd. before rebranding to Lutronic Corporation in 2006.

WebsiteN/A
IndustryMedical - Devices
Trades inKRW

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 10 Oct 2023

Lutronic Corporation (085370.KQ)

085370.KQ · KOE · Healthcare
36,700.00 KRW-0.14%
Benchmarks
Financialsin KRW
20212022TTM
About

Lutronic Corporation, headquartered in Goyang, South Korea, is a global innovator in the development and distribution of advanced laser and related technologies for both aesthetic and medical applications. The company's extensive portfolio encompasses a variety of sophisticated solutions, including: HOLLYWOOD SPECTRA, a distinguished laser platform with proprietary capabilities to diminish unwanted pigmentation and enhance skin luminosity. Accufit, designed to deliver direct muscle activation treatments for refined aesthetic outcomes. LUTRONIC GENIUS, which ensures exceptional precision with every energy pulse. CLARITY II, a cutting-edge dual-wavelength laser platform featuring intelligent breakthrough functionalities. LaseMD Ultra, providing tailored patient results with virtually no recovery period. SPECTRA XT, recognized as a state-of-the-art medical device. CLARITY, another dual-wavelength platform offering broad treatment versatility and increased operational speed. LASEMD, an adaptable platform capable of implementing a cosmeceutical delivery system for comprehensive skincare. SPECTRA, known for its effective treatments that require minimal patient downtime. PICOPLUS, specifically engineered for the treatment of melasma. ACTION II, which utilizes specialized multiple stacking fractional technology, allowing clinicians to control ablation depth and coagulation for a nearly painless procedure. Lutronic’s offerings further extend to include: eCO2, a premier fractional ablative CO2 laser. INFINI, a unique technology that delivers fractional radiofrequency energy through insulated microneedles. HEALITE II, which therapeutically harnesses incident light to modulate cellular function. SOLARI, an advanced IPL system. In addition to individual devices, the company provides integrated solutions such as: TotalSkin Solution, a comprehensive approach designed to address all layers of the skin and satisfy diverse patient expectations. KeraFactor Peptide Complex, a specialized treatment targeting hair and scalp health. The Hollywood Laser Peel, a swift and comfortable procedure facilitated by the Lutronic Spectra laser platform. Founded in 1997, the company was initially known as Max Engineering Ltd. before rebranding to Lutronic Corporation in 2006.

IndustryMedical - Devices
Trades inKRW

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free